Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01739127
What this trial is testing

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

Who this might be right for
Psychotic DisordersBipolar DisorderMetabolic Syndrome X
University of British Columbia 83
Large-scale testing (Phase 3)Study completedNCT00210769
What this trial is testing

The Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203
Large-scale testing (Phase 3)Study completedNCT00161018
What this trial is testing

New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 150
Large-scale testing (Phase 3)Study completedNCT02469155
What this trial is testing

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 696
Not applicableStudy completedNCT01145313
What this trial is testing

Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Otsuka Pharmaceutical Development & Commercialization, Inc. 501
Not applicableNot Yet RecruitingNCT05850585
What this trial is testing

The Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
First Affiliated Hospital Xi'an Jiaotong University 100
Not applicableStudy completedNCT00636896
What this trial is testing

Effects of Modafinil on Olanzapine Weight Gain

Who this might be right for
Weight Gain
Neuropsychiatric Research Institute, Fargo, North Dakota 50
Testing effectiveness (Phase 2)Study completedNCT00628290
What this trial is testing

Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis

Who this might be right for
Schizophrenia
University of Cologne 42
Large-scale testing (Phase 3)Study completedNCT02013609
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

Who this might be right for
MDD
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT07342764
What this trial is testing

Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)Antipsychotic-induced Weight Gain
Sultan Qaboos University 110
Post-approval studies (Phase 4)Study completedNCT00895921
What this trial is testing

Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

Who this might be right for
Diabetes
Veterans Medical Research Foundation 30
Testing effectiveness (Phase 2)Study completedNCT00309413
What this trial is testing

A Clinical Trial on the Antipsychotic Properties of Cannabidiol

Who this might be right for
SchizophreniaPsychotic Disorders
University of Cologne 29
Not applicableLooking for participantsNCT05748990
What this trial is testing

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Who this might be right for
SchizophreniaHealthy
Centre for Addiction and Mental Health 20
Not applicableStudy completedNCT00956189
What this trial is testing

Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome

Who this might be right for
Metabolic Syndrome X
National Taiwan University Hospital 132
Not applicableStudy completedNCT02220504
What this trial is testing

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Testing effectiveness (Phase 2)Study completedNCT00561587
What this trial is testing

Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study

Who this might be right for
Alcohol Relapse PreventionAlcoholismAlcohol Drinking+2 more
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Post-approval studies (Phase 4)Study completedNCT00205699
What this trial is testing

Metabolic Effects of Antipsychotics in Children

Who this might be right for
AggressionAttention Deficit-HyperactivityOppositional Defiant Disorder+2 more
Washington University School of Medicine 144
Not applicableStudy completedNCT00399334
What this trial is testing

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Janssen-Cilag, S.A. 1,607
Not applicableStudy completedNCT00818298
What this trial is testing

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 12
Large-scale testing (Phase 3)Study completedNCT00649844
What this trial is testing

A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 147
Next Page